InBody Co.,Ltd (KOSDAQ:041830)

Market Cap	385.28B
Revenue (ttm)	217.55B
Net Income (ttm)	30.62B
Shares Out	12.19M
EPS (ttm)	2,409.58
PE Ratio	13.11
Forward PE	11.71
Dividend	400.00 (1.26%)
Ex-Dividend Date	Mar 28, 2025

Volume	95,641
Average Volume	45,914
Open	31,900
Previous Close	31,750
Day's Range	31,250 - 32,400
52-Week Range	20,700 - 32,050
Beta	0.51
RSI	69.90
Earnings Date	Nov 11, 2025

About InBody Co.,Ltd

InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in bariatric, cardiology, diabetes, frailty and aging, ICU, lymphedema, nephrology, nutrition, oncology, sports medicine, and rehabilitation and physical therapy applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 1996
• Employees: 342
• Stock Exchange: KOSDAQ
• Ticker Symbol: 041830

Financial Performance

In 2024, InBody Co.,Ltd's revenue was 204.46 billion, an increase of 20.03% compared to the previous year's 170.35 billion. Earnings were 33.14 billion, a decrease of -9.75%.